Margareta J. Hellmann

Dr. Margareta J. Hellmann

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
MHMargareta J. Hellmann
Margareta J. Hellmann
GMGian Luca Marongiu
Gian Luca Marongiu
CGChristian Gorzelanny
Christian Gorzelanny
BMBruno Moerschbacher
Bruno Moerschbacher
SCStefan Cord-Landwehr
Stefan Cord-Landwehr
Human chitinolytic enzymes trigger growing interest, not only because a wide range of diseases and allergic responses are linked to chitinous components of pathogens, including their interplay with human enzymes, but also due to the increasing use of chitosans in biomedical applications. Here, we present a detailed side-by-side analysis of the only two human chitinases, chitotriosidase and acidic mammalian chitinase, as well as human lysozyme. By analyzing the cleavage of well-characterized chitosan polymers and defined chitin and chitosan oligomers, we report mild processivity and a quantitative subsite preference typical for GH18 chitinases for chitotriosidase and acidic mammalian chitinase. In contrast, lysozyme is negligibly processive and preferentially binds acetylated units at subsites -2, -1, and +1, thus exhibiting an even higher overall preference for acetylated units. A common feature of all three enzymes is their endo-chitinase behavior. For efficient hydrolysis, chitotriosidase or lysozyme require substrates of ≥4 or ≥5 units, respectively, and we identified defined chitosan oligomers which can competitively inhibit chitotriosidase. Knowledge about the enzymes' actions provides insight into the metabolic fate of chitin and chitosans in the human body, which is crucial to develop and approve chitosan applications, and to elucidate molecular mechanisms in chitin-associated diseases.

20 May 2026 in The Cell Surface
Verified
Journal Article
Open access
MHMargareta J. Hellmann
Margareta J. Hellmann
RURajendra Upadhya
Rajendra Upadhya
ETEvelyn Tchoub
Evelyn Tchoub
BMBruno Moerschbacher
Bruno Moerschbacher
JLJennifer K. Lodge
Jennifer K. Lodge
SCStefan Cord-Landwehr
Stefan Cord-Landwehr
The fungal pathogen Cryptococcus neoformans causes fatal cryptococcal meningitis, a significant global health risk. Unlike most fungi, C. neoformans expresses chitin deacetylases that convert its cell wall chitin into chitosan, helping to evade chitin-triggered host immunity. However, it is unclear how the properties and accessibility of these chitosans vary between strains and growth conditions, and how they influence the host immune response. To show how chitin deacetylase activity and growth conditions shape the properties of cell wall chitosans, we present the first comprehensive analysis of the chitosan content, fraction of acetylation (FA), enzymatic degradation products by host chitinases, and accessibility in various Cryptococcus strains, including chitin deacetylase mutants, cultivated under different conditions. Certain chitin deacetylase knockouts, as well as challenging growth conditions, lead to higher FAs and enhanced exposure, associated with stronger host immune responses. The response to cryptococcal chitin/chitosan ranges from low (resulting in cryptococcosis) to adequate (providing effective host defense) and excessive (leading to hyper-inflammation). Correlation between the strength of the immune response and the abundance of chitin-binding proteins was used to rapidly screen a multitude of strains and growth conditions for their immunogenic potential. Our approach provides insight into Cryptococcus-related disease caused by insufficient and excessive immune responses, and may accelerate the development of effective cell-based vaccines.

18 June 2026 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
ETEvelyn Tchoub
Evelyn Tchoub
MHMargareta J. Hellmann
Margareta J. Hellmann
BMBruno Moerschbacher
Bruno Moerschbacher
SCStefan Cord-Landwehr
Stefan Cord-Landwehr
The fungal pathogen Cryptococcus neoformans poses a significant global health concern, accounting for more than 100,000 fatalities among individuals with AIDS alone every year. In contrast to other Basidiomycetes, C. neoformans actively deacetylates the chitin in its cell wall to chitosans. The deacetylation reaction is catalyzed by four chitin deacetylases (CnCDAs 1-4), presumably to evade the chitin-triggered host immunity. In this study, we conducted a comprehensive in vitro characterization of recombinant CnCDA3, revealing a preference for deacetylated units at its -1 subsite, higher activity on longer substrates, and the generation of random acetylation patterns in polymer deacetylation (and N-acetylation) products. In combination with in silico modeling of all CnCDAs, the experimental results suggest that the function of CnCDA3 in vivo may be to further deacetylate cell wall chitosans initially produced from nascent chitin chains by the action of other membrane-associated CnCDAs. Deeper understanding of the actions of these enzymes involved in fungal virulence may facilitate the urgently needed improvement in therapies and the development of effective cell-based vaccines against cryptococcal infections.